Dr. Kim, MD, MPH, is a thoracic medical oncologist and Associate Professor of Medicine specializing in thoracic oncology. He serves as Director of Thoracic Oncology at MedStar Georgetown University Hospital, where he is also an attending physician in medical oncology, and is a member of the Cancer-Host Interactions Program at Georgetown Lombardi Comprehensive Cancer Center. His clinical practice focuses on thoracic oncology, precision cancer therapeutics, and immunotherapy-based treatment planning. His research interests include biomarker-driven precision oncology and mechanisms of treatment resistance, early-phase development of targeted, immune-based, and cellular therapies, and liquid biopsy approaches to molecular profiling and disease monitoring. He is committed to translating innovative therapeutics into routine clinical practice, designing patient-tailored clinical trials, and expanding access to emerging treatments while advancing equity and diversity in oncology research. In addition to his institutional leadership, Dr. Kim serves as Secretary of the International Thymic Malignancy Interest Group and as an editorial board member of Clinical Lung Cancer. His honors include the John F. Potter, MD, Award from Georgetown Lombardi Comprehensive Cancer Center and the Norman Rales Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology. He earned his MD from Sungkyunkwan University School of Medicine and his MPH from the Harvard T.H. Chan School of Public Health, completed his internal medicine residency at the University of Minnesota, and pursued fellowship training in hematology and medical oncology at the National Cancer Institute, National Institutes of Health.
Director of Thoracic Oncology
Medical School
2001 – 2007
Residency
2011 – 2014
Fellowship
2014 – 2017